Barbara Domayne Hayman

Membro del Comitato di Investimento presso Cambridge Enterprise Ltd.

Finance

Health Technology

Consumer Services

Profilo

Barbara Domayne Hayman is currently an Investment Committee member at Cambridge Enterprise Ltd.
and the Chief Business Officer at Autifony Therapeutics Ltd.
She holds a doctorate degree from the University of Oxford.

Posizioni attive di Barbara Domayne Hayman

Società	Posizione	Inizio
Cambridge Enterprise Ltd. Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge.	Membro del Comitato di Investimento	-
Autifony Therapeutics Ltd. Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom.	Corporate Officer/Principal	-

Tutte le posizioni attive di Barbara Domayne Hayman

Formazione di Barbara Domayne Hayman

University of Oxford

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Barbara Domayne Hayman

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Cambridge Enterprise Ltd. Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge.	Finance
Autifony Therapeutics Ltd. Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom.	Health Technology